Joseph Oved is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 84 publications with 597 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 100656007
Telephone
718-208-6349Provider last certified this registry record 29 Jan 2025.
Clinical trials
- JSP191 Antibody Targeting Conditioning in SCID Patients
Sponsor: Jasper Therapeutics, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SOBI, INCProgram year202531 payments$29,782openpaymentsdata.cms.gov ↗
- Stryker CorporationProgram year20251 payment
- Medexus Pharma, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2023–2025 per NIH RePORTER. The latest:
- Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Columbia University Health Sciences
FY2025$650,000R01FD008175 - Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Sloan-Kettering Inst Can Research
FY2024$650,000R01FD008175 - Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)
Sloan-Kettering Inst Can Research
FY2024$647,533R01FD007829
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
Journal of Human Immunity
2025 - Emapalumab for the Treatment of Toxicities Associated with CD19 CAR-T Cells in Adult Patients
Biology of Blood and Marrow Transplantation
2025 - Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”